MedTrace Logo

Evaluation of Non-ablative and Fractional Combination Treatment for Improvement in Skin's Appearance

NCT01403597 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2014-12-02

No results posted yet for this study

Summary

The study is designed to determine the safety, efficacy, patient comfort and patient satisfaction of the combined treatment of Refirme ST and Matrix RF both devices approved under 510k clearances. The evaluations will include skin condition, physician/subject improvement assessment, and subject comfort and satisfaction score by questionnaires.

Conditions

  • Laser Therapy
  • Rejuvenation

Interventions

DEVICE

Refirme ST Applicator and Matrix RF Applicator

5 treatments with combination of devices every 4 weeks to the facial (or sub facial regions).

Sponsors & Collaborators

  • Syneron Medical

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2012-06-30
Completion
2012-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01403597 on ClinicalTrials.gov